REVIEW
Accepted on 26 May 2025
Tiragolumab and TIGIT: Pioneering the Next Era of Cancer Immunotherapy
doi 10.3389/fphar.2025.1568664
- 164 views
470
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: